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Abbreviations 
 
BMI – Body Mass Index 
TAG - Triacylglyeride 
AUC – Area under curve 
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ABSTRACT 
 
 
Dietary fibres are of particular interest in the prevention and management of 
obesity and consequent pathologies. Amongst the proposed mechanisms of 
action of fibre are the modulation of nutrient uptake from the small intestine. 
We have used a cross-over study design in human subjects to monitor the 
uptake of glucose, cholesterol and triacylglycerides (TAG) in human subjects 
with normal and high body mass index (BMI). Our pilot data demonstrate that 
uptakes of glucose, TAG and cholesterol are all increased with increasing 
percentage body fat, and that a 1.5g dose of a strong-gelling alginate may 
restore uptake of cholesterol and glucose to normal levels.  
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1. INTRODUCTION 
 
Diets rich in fibre are thought to be preventative in the pathogenesis of obesity 
[1,2].  This has variously been attributed to the low energy density of high fibre 
diets, a reduced rate of gastric emptying and/or potential for enhanced gastric 
stretch following fibre ingestion.  However, the role that dietary fibre plays in 
the prevention of weight gain might be due in part to the association it has 
with improvements in the lipid profile and glucose handling.  Populations with 
high fibre intakes have lower serum cholesterol.  The reduced uptake of 
cholesterol [3] increased excretion of lipids as faecal bile acid [4,5], coupled 
with reduced absorption of glucose - leading to altered insulin secretion and 
therefore lowered cholesterol synthesis - have all been presented as potential 
candidates for the mechanism of action of fibre in relation to cholesterol 
lowering.   
 
Wu & Peng [4] investigated various dietary fibres (konjac, pectin, algin and 
agar) in rats on lipid-rich diets.  All the fibres similarly prevented a rise in 
serum cholesterol (with no change in triglyceride).  In addition, the daily output 
of faecal bile was increased for all four fibres when compared to the normal 
group and control group.  Rats fed on guar gum-rich diets for sixty days 
showed significantly reduced levels of blood serum cholesterol and 
triglyceride compared to control rats. These findings were coupled with 
reduced blood serum glucose for the first month of the experiment.  Studies in 
humans involving dietary supplementation with soluble fibre have 
demonstrated cholesterol-lowering effects [7,8,9]. These effects seem to be 
specific to fibre preparations and not universal [10].    
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Some fibres are additionally thought to modulate glycaemia.  The glycaemic 
response to a carbohydrate load was significantly reduced in healthy female 
volunteers following addition of Nori seaweed [11].  Likewise Lavin and Read 
[12] demonstrated significantly reduced peak glucose and 2-hour area under 
the curve plasma glucose in healthy male volunteers following a 30% glucose 
drink with 2% guar gum compared to control.  In a study of free-living, healthy 
adults, fasting glucose and total cholesterol levels were significantly reduced 
following a 3 month prescribed high fibre diet, however, fasting triglyceride 
levels remained unaltered during this time [13].  In general, soluble fibre does 
not seem to have potential triglyceride lowering properties [10 13].  However, 
some animal studies [6] and human studies [15] suggest otherwise. Jenkins et 
al. [15] conducted a randomised, controlled two-way crossover study to 
investigate the effect of a high fibre diet on the lipid profile of hyperlipidaemic 
subjects, demonstrating a significant total cholesterol and triglyceride-lowering 
effect of the high-fibre diet compared to the control diet.   
 
The polyuronic saccharide sodium alginate is a fibre isolated from the cell 
walls of brown algae and some bacteria [16].  Alginates have wide ranging 
applications in the food and pharmaceutical sectors [17].  The modifiable 
primary structure of alginates determines their physical and chemical 
properties [17] and therefore their usefulness in various settings. Alginate is 
capable of forming a cross-linked gel network in the presence of divalent 
cations such as calcium.  
To date there are few studies on the effect of sodium alginate on lipaemia and 
glycaemia. There is an inverse linear relationship between supplementary 
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dietary fibre intake and plasma cholesterol for alginate and an associated 
increase in total faecal bile levels [5].  Kimura et al. [18] examined a range of 
alginate formulations in rats, showing increased cholesterol excretion and 
improved glucose tolerance.  Parallel findings with studies of ileostomy 
patients support an increase in fatty acid excretion occurring in sodium 
alginate supplementation on a low-fibre diet [19].  Wolf et al [20] demonstrated 
a fall in peak glycaemia following ingestion of a viscous alginate drink. 
Williams et al [21] showed that incremental peak glucose was significantly 
lower (p < 0.001) and positive incremental area under the curve (AUC) 
(T+180mins) was significantly reduced (p < 0.01) after consumption of an 
alginate-containing bar.  Torsdottir et al. [22] showed similar results in type-2 
diabetic males.  
The literature suggests that sodium alginate may have particular value in 
management of obesity through alterations in nutrient uptake. This pilot study 
set out to use a cross-over design to address whether a sodium alginate 
beverage, specifically formulated to gel within the gastrointestinal tract, could 
modulate normal physiological lipaemic, glycaemic and cholesterolaemic 
responses in subjects across a range of body compositions. The data indicate 
that uptake of all three nutrients is perturbed in overweight subjects relative to 
their normal counterparts and that the increased uptake of cholesterol and 
glucose can be reduced to normal levels by alginate. This offers scope for the 
use of alginate in the management of obesity and related comorbidities 
including diabetes.  
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M2. METHODS 
 
2.1 Subjects 
The study was approved by Sheffield Hallam University Ethics Committee 
(reference: OMREC/FIRC/2006/01).  Fourteen healthy male subjects were 
recruited via e-mail circulation lists and electronic message boards in 
accordance with previously used criteria [23].  Subjects gave informed 
consent to take part in the study.  The subject profile is shown Table 1. 
 
2.2 Design 
The study was conducted as a randomised, single-blinded, controlled, two-
way crossover trial.  On the intervention arm of the trial, subjects ingested a 
100ml, strong-gelling sodium alginate-based drink.  This formulation included 
1.5g of sodium alginate in the presence of calcium carbonate [23].  A 
comparably viscous 100ml drink containing 0.25g of hydroxypropyl 
methylcellulose was used as a control.  Both drinks were vanilla flavoured.  A 
washout period of a minimum of 7 days was set in order to ensure there was 
no carryover effect from treatment to control or vice-versa.  Subjects were 
given a standard frozen, microwavable meal, consisting of vegetable lasagne, 
steamed mixed vegetables and syrup sponge-pudding with custard, to 
consume on the evening prior to the study.  Subjects were asked to consume 
the entire meal and nothing else between 6pm and 10pm on the evening prior 
to the study.  From 10pm, subjects undertook a 10-hour fast before travelling 
to the study to begin the acute phase of the experiment.  Subjects were asked 
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to minimise energy expenditure throughout this period.  These conditions 
were upheld for each arm of the study 
 
Anthropometric measures were made on both experimental mornings of the 
study prior to breakfast; height was measured using a free-standing portable 
stadiometer and body fat percentage and weight were determined using 
Tanita BF-626W scales. 
 
 At 9am on study days a controlled breakfast (similar to that described by 
other workers [24, 25])  of 60g of Kellogg’s Crunchy Nut CornFlakes, 125g 
semi-skimmed milk and 200g UHT orange juice was consumed by each 
subject.  Subjects were thereon limited to consumption of water (maximum 
one litre) and sedentary activity until administration of 100ml of the preload 
drink (either the alginate formulation or control) at noon.  
  
In order to allow measurement of lipaemic and glycaemic response, the test-
lunch contained sufficient fat and carbohydrate to illicit a response and, to 
ensure constancy of intake for subsequent uptake measurements, all subjects 
were provided with the same portion size.  The test lunch was a meal of 100g 
Sacla™ Italia Vine-ripened Tomato & Mascarpone Stir Through sauce: 300g 
cooked penne pasta.  The meal provided 57%, 13% and 30% of total energy 
from carbohydrate, protein and fat respectively as analysed by NetWISP 
(version 3.0 for Windows,Tinuviel Software, Anglesey, UK). 
 
2.3 Blood collection and analysis 
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Capillary blood samples were taken from the finger at 0 minutes (15 minutes 
prior to preload) and at the following intervals (mins): 30 (pre-prandial), 105, 
120, 135, 150, 165, 180, 195, 225.  Samples were taken using an Accu-
check® Softclix® Pro lancing device.  Two 30µl samples were collected in 
uncoated capillary pipettes and applied immediately to Reflotron® reagent 
strips for cholesterol and for triacylglycerides (TAG).  The Reflotron® Plus 
(Bio-Stat Diagnostic Systems, Cheshire, UK), a reflectance photometer, was 
then used to analyse each sample.  A final droplet sample was collected using 
OneTouch® Ultra® Test Strips with FastDrawTM design.  This was analysed 
using the OneTouch® Ultra® Blood Glucose Monitoring System (Lifescan 
Inc., Bucks, UK).  
 
2.4 Statistical analysis 
Measurements made of blood parameters (e.g. glucose) across time allowed 
the generation of a curvce from which area-under-the-curve (AUC) data (REF) 
could be obtained.  All blood measures were converted to change from 
baseline area under the curve (AUC).  AUC data were generated in 
accordance with the trapezoidal rule (with subtraction of the basal values) as 
previously described by Porcellati et al. [26] using NCSS (Hintze, 2004, NCSS 
and PASS Number Cruncher Statistical Systems, Kaysville, Utah.). Initial 
analyses used a  
Ppaired samples t-tests were used to compare findings AUC values between 
the intervention and control arms of the trial (SPSS, version 13.0 for Windows, 
SPSS Inc., Chicago, IL, USA).  In order to evaluate the effect  across differing 
bodyfat measures, Pearson Product Moment Correlations (REF [27] we) were 
Formatted: Highlight
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performed to demonstrate the relationship between body fat percentage and 
nutrient uptake (SPSS, version 13.0 for Windows, SPSS Inc., Chicago, IL, 
USA). All graphical presentations were produced using SPSS (version 13.0 
for Windows, SPSS Inc., Chicago, IL, USA). Data with a probability of <0.05 
were considered significant. 
 
 11 
R3. RESULTS 
3.1 Initial analyses 
Measures were made of circulating nutrients following a balanced meal in all 
subjects after either the alginate or control preload.  Data were analysed by 
subject as the change from baseline AUC (for each whole blood measure 
following the meal).  
Initial analyses explored differences in AUC and peak levels between the 
alginate and control groups.  We observed no significant differences in AUC 
cholesterolaemia, triglyceridaemia or glycaemia (over 225 minutes) following 
an alginate preload compared to the control (paired-samples t-test: p=.764, 
p=.874 and p=.874 respectively, data not shown).  Additionally, there were no 
significant differences following alginate compared to the control for peak 
blood cholesterol, triglycerides or glucose (paired-samples t-test: p=.075, 
p=.895 and p=.687, data not shown).  These preliminary analyses predicated 
on the assumption that uptake would be unaffected by body composition.  
However, when this factor was taken into account with the analysis, significant 
differences in response to alginate versus control were observed.  
 
3.2 Alginate modulates uptake of cholesterol and glucose uptake, but 
not TAG uptake in a body-composition-dependent manner 
We observed a significant positive correlation between AUC cholesterolaemia 
and body fat percentage (r= 0.59, P=0.026; Fig 1A and D) following 
preloading with the hypromellose control, indicating that with increasing body 
fat subjects had greater uptake of cholesterol from a meal of fixed nutritional 
content.  Following alginate ingestion, the positive significant correlation 
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between AUC cholesterolaemia and body fat percentage was weakened and 
reduced to a non-significant level (r=0.14, Fig 1A and D). 
When subjects were grouped by BMI, significant attenuation of mean peak 
blood cholesterol was seen following alginate ingestion in subjects with an 
overweight/obese BMI (n = 5) compared to the control (paired-samples t-test, 
p=.039). No such significant finding was demonstrated for subjects with 
healthy BMIs (n = 9).   
Figure 1B shows correlation between AUC glucose and body fat percentage. 
In this analysis the control group showed a strong positive correlation 
between total glucose uptake and body fat (r=0.32) after preload with the 
hypromellose.  When alginate was used as the preload, the strength of the 
correlation was reduced (r= 0.15), demonstrating the potential to repair the 
altered glycaemic response of the overweight/obese subjects to the levels 
seen in normal subjects.  Analyses of the data for triacylglyceride showed no 
change to the correlation observed in the control condition compared to with 
alginate (Fig 2C and D).  
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D4. DISCUSSION 
The early onset of metabolic syndrome is marked by increasing insulin 
resistance and it is recognised that this will result in altered uptake kinetics for 
glucose with consequences for impaired maintenance of blood glucose and 
appetite. Our findings support this literature and suggest that our study cohort 
showed altered glucose uptake in the high body-fat group by comparison with 
the normal body fat group. Three cross-sectional studies have reported that 
subjects with high BMI have elevated levels of blood cholesterol [268, 279, 
2830]. We report herein and for the first time that cholesterol uptake is altered 
in subjects with elevated BMI or body fat.  This novel observation suggests a 
contributory mechanism to the incidence of elevated blood cholesterol and 
thereby many of the co-morbidities of metabolic syndrome, including coronary 
heart disease and other vascular diseases. We also noted that there was 
altered uptake kinetics of triacylglycerol with increasing body fat. Taken 
together these data may imply a common underlying cause for altered uptake 
in subjects with high body fat. 
 
Having identified the link between altered body fat and nutrient uptake, we 
have addressed the potential of alginate to modulate this effect. Using a meal 
of fixed nutritional content in order to control intake level, and a randomised, 
blinded, cross-over trial structure, we have shown that the strong correlations 
between uptake and body fat are reduced in strength by preloading with this 
alginate formulation. The fact that the intervention removes the correlation 
observed in the absence of the preload suggests alginate is acting to restore 
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rates of uptake in subjects with elevated body fat to the levels of uptake in 
normal subjects for both cholesterol and glucose.   
It is unlikely that this will be attributable to altered rate of gastric emptying as 
we saw no alteration in time to peak uptake with either nutrient, as the timing 
and size of the TAG uptake peak was the same with and without alginate, and 
the observations held for AUC (an indicator of total uptake over time). Alginate 
is therefore likely acting at the level of small intestinal uptake by altering the 
availability of nutrients to active uptake mechanisms.  
We have therefore demonstrated the potential of alginate to offset pre-clinical 
metabolic syndrome symptoms including insulin-resistance; to treat type II 
diabetes mellitus; treat hypercholesterolaemia and consequently reduce risk 
of development of cardiovascular disease.  Following studies showing the 
efficacy of this alginate preparation in modulating calorie intake [23], this study 
suggests that alginate may modulate appetite through reduction in post-
prandial glucose spiking and be highly effective in overweight and obese 
subjects. 
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Figure legends 
 
Figure 1. Relationships between nutrient uptake and body composition.  
14 subjects were fed a meal of fixed nutritional value after a preload of either 
alginate or control. Uptakes of glucose, cholesterol and TAG were measured 
at intervals for 195 minutes postprandially. Uptake was calculated as total 
AUC for each curve.  Panel A shows correlations between total AUC for 
cholesterol and % body fat for subjects consuming the control preload (open 
circles) and alginate (filled circles). Correlation curve for control is shown as a 
dotted line and for alginate as a solid line. Panel B shows the same analysis 
for glucose. Panel C shows the same analysis for TAG. Panel D summarises 
the Pearson’s Correlation coefficients for curves in Panels A-C. 
 
Table 1. Study group characteristics 
 
 
Table 2. Pearson’s Correlation coefficients for Total AUC versus 
Bodyfat.  
Correlation coefficients (r values) are shown for the correlations shown in 
figures 1a-1c. 
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